a) Ethics approval and consent to participate:
The study was approved by the institutional review board of the Cleveland Clinic (IRB # 11-441). All subjects provided written informed consent
b) Consent for publication:
Not applicable
c) Availability of data and material:
Available upon request
d) Notation of prior abstract publication/presentation:
Some results of this study have been reported in the form of a poster at the American Thoracic Society International Conference in May 2019.
e) Funding:
A.R.T is supported by NIH grand # R01HL130307. M.K.A was supported by the Egyptian Ministry of Higher Education and Scientific Research Scholarship program grant.
f) Competing interest:
Sami Al Ampnti MD: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Allaa Almoushref MD: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Tawfeq Naal MD: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Celia Melillo BS: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Mostafa K. Ahmed MD: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Chatterjee, Soumya MD: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Kristin Highland MD: The author has received speaking fees from United Therapeutics, Actelion, Bayer, Boehringer Ingelheim, Gilead Sciences, and Reata Pharmaceuticals. The author has received grants and contracts from United Therapeutics, Actelion, Bayer, Boehringer Ingelheim, Eiger Biopharmaceuticals, Gilead Sciences, Genetics Pharmaceuticals, and Reata Pharmaceuticals. The author is working as a consultant for United Therapeutics, Boehringer Ingelheim, and Actelion.
Kulwant S. Aulak Ph.D.: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Raed A. Dweik MD, MBA: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
Adriano R. Tonelli MD, MSc: The author has no significant conflicts of interest with any companies or organizations whose products or services may be discussed in this article.
g) Authors' contributions:
Sami Al Ampnti MD: Participated in the data collection, statistical analysis, interpretation of the results, writing and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Allaa Almoushref MD: Participated in the design of the study, data collection, interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Tawfeq Naal MD: Participated in the data collection, interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Celia Melillo BS: Participated in the data collection, interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Mostafa K. Ahmed MD: Participated in the data collection, interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Chatterjee, Soumya MD: Participated in the interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Kristin Highland MD: Participated in the interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Kulwant S. Aulak Ph.D.: Participated in the data collection, interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Raed A. Dweik MD, MBA: Participated in the interpretation of the results and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted.
Adriano R. Tonelli MD, MSc: Participated in the design of the study, data collection, statistical analysis, interpretation of the results, writing and critical revision of the manuscript for important intellectual content and final approval of the manuscript submitted. Dr. Tonelli is the guarantor of the paper, taking responsibility for the integrity of the work as a whole, from inception to published article.
h) Acknowledgments:
United Therapeutics kindly provided the treprostinil (Remodulin 1mg/mL) used in the study, as part of an investigation-initiated proposal. Besides receiving treprostinil vials, no other monetary support was received from the company for the present study. The authors are indebted to Jennie Newman, L.P.N., for her continued assistance during this project, and to Yvonne Al Abdi for her help in producing figure 1.